Cinnamomi cortex was applied to mitigate joint injury since ancient China. However, the effect of Cinnamomi cortex on gouty arthritis (GA) was rarely reported. This study aimed to explore the effect of Cinnamomi cortex on monosodium urate (MSU)-induced acute GA (AGA) in rats, and clarify the underlying mechanism. The results showed that Cinnamomi cortex extract (CE) containing rich polyphenols and flavonoids alleviated joint swelling and inflammation by reducing programmed cell death in MSU-induced AGA rats. Network pharmacology analysis showed that CE's predictive inflammatory pathways included nuclear factor-κB (NF-κB) and necroptosis pathways. CE reduced expression of pyroptosis-related regulators including Gasdermin D and Caspase 1 via regulating NF-κB/NOD-like receptor thermal protein domain associated protein 3 signaling pathway in AGA rats. In conclusion, this study provided a theoretical basis for Cinnamomi cortex applied as a new veterinary medicine to protect against GA.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11187596 | PMC |
| http://dx.doi.org/10.1292/jvms.23-0085 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the mechanism of Cinnamomi Cortex against morphine addiction using network pharmacology and molecular docking analyses.
Pak J Pharm Sci
May 2024
Department of Pharmacology of Chinese Medicine, College of Traditional Chinese Medicine, Southern Medical University, Guangzhou Guangdong, China.
Cinnamomi Cortex is a commonly used herb with a variety of pharmacological effects. We investigated the molecular mechanisms by which Cinnamomi Cortex antagonises morphine addiction (MA) using network pharmacology and molecular docking techniques in a morphine-dependent rat withdrawal model. The antagonistic effect of Cinnamomi Cortex was observed by inducing withdrawal symptoms in morphine-dependent rats through a dose-escalation method.
View Article and Find Full Text PDFMechanisms of Cinnamomi Cortex against Diabetes Mellitus Explored by Network Pharmacology combined with Molecular Docking and Experimental Validation.
Endocr Metab Immune Disord Drug Targets
September 2024
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Objective: Cinnamomi cortex (CC), a traditional Chinese herbal medicine, exhibits antidiabetic properties, yet the underlying mechanisms are not fully understood. Our study combined network pharmacology, molecular docking, and experimental validation to elucidate the antidiabetic mechanisms of CC.
Methods: Active components of CC and their potential antidiabetic targets were identified through TCMSP, DisGeNET, and GeneCards.
Pharmacokinetics, safety, and efficacy of Fuqi Guben Gao in the treatment of kidney-yang deficiency syndrome: a randomized, double-blind phase I trial.
Front Pharmacol
June 2024
Institute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Beijing, China.
Article Synopsis
- Fuqi Guben Gao (FQGBG) is a botanical drug used to treat nocturia linked to kidney-yang deficiency by combining several traditional medicinal plants, but its safety and pharmacological effects need further study.
- Recent research on FQGBG demonstrated its effectiveness in reducing urination and improving immune organ damage in rat models of kidney-yang deficiency, while also assessing its safety in a clinical trial with healthy participants.
- The results indicated significant improvements in symptoms with no major adverse events occurring during dose escalation, although some minor side effects were reported; pharmacokinetic analysis showed varying levels of certain compounds within FQGBG.
Immobilized PAD4 enzyme on magnetic nanoparticles for screening natural inhibitors from traditional Chinese medicines.
Talanta
October 2024
Key Laboratory of Resource Biology and Modern Biotechnology in Western China, College of Life Science, Northwest University, Xi'an, Shaanxi Province, 710069, PR China. Electronic address:
Dysregulation of peptidyl arginine deiminase 4 (PAD4) is involved in a variety of diseases including rheumatoid arthritis (RA) and Alzheimer's disease (AD), and it has emerged as potential and promising therapeutic target. However, no PAD4 inhibitor is ready for clinical use. Immobilized enzyme screening technology has gained increasing attention due to its low cost, reusability, easy separation from the reaction mixture, and resistance to changes in environmental conditions.
View Article and Find Full Text PDFProtection of Gueichih-Fuling-Wan on cerebral ischemia-induced brain injury in rodents is mediated by trans-cinnamaldehyde via inhibition of neuroinflammation and apoptosis.
Biomedicine (Taipei)
June 2024
Department of Pharmacy, China Medical University Hospital, Taichung 404327, Taiwan.
Background: Stroke is the leading cause of mortality and morbidity worldwide, and an effective therapeutic strategy for the prevention of patients with cerebral ischemia induced brain injury is lacking. Traditional Chinese medicine with neuroprotective activities might be beneficial and provide alternative therapeutic opportunities for cerebral ischemia.
Purposes: This study aimed to evaluate the neuroprotection and possible mechanisms of Gueichih-Fuling-Wan (GFW), its' constitutive herbs, and their active compounds on cerebral ischemia/reperfusion (I/R)-induced brain injury in rodents.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!